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Towards the synthesis of calotropin and related
cardenolides from 3-epiandrosterone: A-ring
related modifications†
Vanessa Koch,a Martin Niegerb and Stefan Bräse *a,c
Calotropin and related cardiac glycosides isolated from plants such as calotropis gigantea represent an
interesting target for biological investigations and are based on a cardiac steroid that is doubly connected
to a sugar moiety. This naturally occurring family of cardiac glycosides was not only reported to have
similar cardiac properties as the drugs digitoxin and digoxin, but also show cytotoxic activity against
several cancer cell lines. Herein, the first synthetic access to these molecules is reported highlighting the
required transformations of the A-ring of the steroid when starting from commercially available and in-
expensive 3-epiandrosterone. Our strategy is based on a regioselective C–H oxidation of the methyl
group at C-17 delivering the 2α,3β-trans-diol moiety at the same time and ensuring its connection to the
sugar unit.
Introduction
Cardiac glycosides were already known to the ancient
Egyptians over 3000 years ago and have been always used in
folk medicine.1 Since the 18th century, cardiac glycosides from
the digitalis plant typified by digitoxin (1) or digoxin (2) were
successfully applied by Withering for the treatment of conges-
tive heart failure.2,3 This was later attributed to the so called
“cardiotonic effect” which is correlated to an inhibitory inter-
action with the sodium pump (Na+/K+-ATPase) leading to an
increased intercellular sodium and calcium ion concentration.
The inhibition finally results in a more powerful and faster
contraction of the cardiomyocytes explaining the successful
application of these drugs.4,5
Cardiac glycosides show several characteristic features if
compared to other classes of steroids. For example, they
possess a tertiary hydroxyl group at C-14 and a β-oriented bute-
nolide substituent at C-17 (Fig. 1).6 The A/B and C/D rings of
cardiac glycosides are usually both cis-fused whereas cardiac
glycosides isolated from the milkweed family Asclepiadaceae
differ in having a trans-junction of the A/B rings.7 While digi-
toxin (1), digoxin (2) and ouabain (3) are attached via their
3β-OH group to the sugar moiety, the cardenolides calotropin
(4) and their related cardenolides (5–10) are connected by the
2α- and 3β-position to the sugar unit forming a 1,4-dioxane
ring.8–15 This double linkage of the steroidal pattern to the
carbohydrate explains the unusual stability towards acids16
and reduction.17
Calotropin (4) and related cardenolides (5–10) bear more-
over an aldehyde functionality at C-1916,18–20 that distinguishes
Fig. 1 Different cardiac glycosides and their connection of the steroidal
aglycon to the sugar fragment. Calotropin (4) is doubly attached to the
sugar moiety forming a 1,4-dioxane ring, while digitoxin (RvH, 1),
digoxin (RvOH, 2) and ouabain (3) are linked to the sugar unit via the
3-OH group.
†Electronic supplementary information (ESI) available. CCDC 1822521–1822529.
For ESI and crystallographic data in CIF or other electronic format see DOI:
10.1039/d0qo00269k
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them from gomphoside derivatives and occurs occasionally in
some cardenolide classes, for instance also in k-strophanthin.
Most cardiac glycosides contain one to four sugar residues
attached to the genin inducing both the water solubility and
the ability to bind the heart muscle.7,21 In the case of the
Calotropin family, many different substitution patterns were
found at the sugar moiety (Fig. 2). Modifications occur mostly
at C-3′ including the acetylation22 or epimerization9,10,15,23 of
the hydroxyl group, but also its oxidation.10,11,14,15 Moreover,
an attachment of a thiazolidine9–11,13,15 or a
dihydrothiazolidine11,14,15 moiety was discovered at C-3′ as a
frequent modification of the sugar building block demonstrat-
ing the broad diversity of the presented cardenolide class.
While cardiac glycosides were used by the ancient
Egyptians and Romans as heart tonic, emetic and diueretic,24
natives in Africa took advantage of their toxic effects by apply-
ing calotropis plants as arrow poison.25,26 In lower doses,
extracts of these plants exhibit a wide range of biological activi-
ties including anti-inflammatory,27–30 analgesic,31,32 anti-
microbial27,33 or wound-healing properties.34,35 In the last
years, cytotoxic and antitumor effects of cardenolides glyco-
sides have been reported more frequently.36–42 The mode of
action is still under investigation leading to several con-
clusions. For instance, Ishibashi and coworkers showed that
calotropin (4) and related compounds inhibit the wnt signaling
pathway in a dose-dependent manner.43 Although these carde-
nolides have been studied more than one century8 and are
reported to have similar cardiac properties to well-established
cardiac glycosides, they remain less investigated.40,44
Motivated by the interesting biological properties of the car-
denolide family, we envisioned a modular semisynthesis from
easy available starting materials that enables the modification
of the lead structure on all parts of the molecule in order to
gain insight into the structure activity relationship. A retrosyn-
thetic analysis divides calotropin (4) into two fragments
(Scheme 1), one of which is based on a sugar unit, while the
other gives calotropagenin (11) as steroidal building block.
As steroidal precursor, we chose commercially available
3-epiandrosterone (12) possessing already six of the eight
required stereogenic centers. Nevertheless a couple of modifi-
cations at the A-ring of the steroid are required including the
installation of the 2,3-trans-diol and the oxidation of C-19.
Herein, we wish to report on the introduction of the oxygen
moiety at C-19 allowing later on the generation of the aldehyde
as well as the installation of the 2α,3β-diol which allows the
attachment to the sugar unit according to Lichtenthaler’s
glycosylation.45
Results and discussion
Our approach for the synthesis of calotropin (4) is based on
the idea to introduce the 2,3-trans-diol and the oxygen func-
tionality at C-19 via a remote intramolecular free radical C–H
oxidation giving the key intermediate 13. A Lewis-acid pro-
moted ring-opening of the A-ring bridging ether in 13 should
deliver the desired trans-diol as well as the desired oxygen
functionality at C-19. As suitable precursor for the intended
remote C–H oxidation, the C-3 acetylated cis-diol 14 was
chosen (Scheme 2).
The key intermediate 14 was initially synthesized according
to typical steroidal transformation leading to the first gene-
ration approach (Scheme 2, highlighted in red). This approach
is based on the epoxidation and ring-opening of the acetyl
enol ether 16. Since this route is not compatible with the keto
group at C-17, the latter was reduced and the obtained alcohol
was protected with either an acetyl (14-Ac) or a benzyl protect-
Scheme 1 Retrosynthetic analysis of calotropin (4) gives calotropa-
genin (11) as steroidal fragment. Highlighted are the desired transform-
ations for the A/B-ring system with 3-epiandrosterone (12) as starting
material. This includes the installation of the trans-diol at C-2/C-3 and
the oxidation to an aldehyde at C-19.
Scheme 2 Overview of the two concepts for the installation of the
trans-diol moiety at C-2/C-3 and the aldehyde at C-19 starting from
3-epiandrosterone (12). While the first generation approach (red) is
based on an epoxidation of the acetyl enol ether 16, the second gene-
ration approach (green) relies on a diastereoselective Sharpless dihy-
droxyation of 15 followed by a regioselective acetylation of C-3’s
hydroxyl group.
Fig. 2 Calotropin (4) and selected cardenolide glycosides (5–10) iso-
lated from the milkweed family Asclepiadaceae.
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ing group (14-Bn). 3-Epiandrosterone (12) was therefore trans-
formed to the keto compound 17 bearing (a) a TBS-protected
or (b) a benzyl-protected alcohol at C-17 (Scheme 3). Treatment
of 17 with Ac2O and catalytic amounts of HClO4 produces
regioselectively the acetyl enol ether 16 whereby the acidic con-
ditions replace the TBS-group by an acetyl group. After a sub-
strate-induced stereoselective epoxidation from the α-face, the
corresponding 2,3-epoxides 18 were opened with pyridine in
toluene to give the 3-oxo 2β-acetate 19 in good yields. Under
basic conditions, 19 rearranged to the 2-oxo 3β-acetate 20 by
1,2-carbonyl transposition. The isomerization proceeds by an
enolisation followed by an acyl group migration presumably
via the cyclic intermediate I that has been reported first by
Fieser et al.46–48 The structure was determined by 2D NMR
experiments and X-ray crystallography (the crystal structure of
20-Ac can be found in the ESI†) confirming the presumed con-
figuration of the acetoxy group. Side reactions such as the clea-
vage of the acetyl protecting group at the A-ring or epimeriza-
tion could not be completely suppressed by modifications in
reaction time or the choice of the base and solvent. The
reduction of the 2-keto group with NaBH4 provided the desired
precursors 14-Ac and 14-Bn in satisfying yields and good
diastereoselectivities. An X-ray crystal structure was obtained
from 14-Ac confirming the molecular structure and the con-
figuration at C-2 and C-3 in the solid state. In addition, NOESY
experiments in combination with further 2D NMR experiments
verified the cis-configuration of the hydroxyl and acetoxy
group. The first generation approach including ten classical
steroidal transformation steps delivered the precursor with an
acetyl protecting group at C-17 14-Ac with 13% overall yield,
while the corresponding benzyl protected precursor 14-Bn was
delivered with 6.5% yield. It is noteworthy that this route
requires two additional steps including the cleavage of the pro-
tecting group and reoxidation of C-17 for being applicable for
the synthesis of calotropin since the installation of the buteno-
lide moiety demands a keto functionality at C-17 as it was pre-
viously shown by us.49
The obtained poor overall yield of the required precursor
along with the number of synthetic steps, encouraged us to
search for an alternative route maintaining the oxidation state
at C-17 (Scheme 2, green route). The novel approach relies on a
Sharpless dihydroxylation of androst-2-ene 15 followed by a
regioselective acetylation of the C-3 hydroxyl group. With
androst-2-ene 15 as key intermediate, the opportunity of a
diversity orientated synthesis was given allowing the synthesis
of several 2,3-diols (Scheme 4).
Androst-2-ene 15 was prepared from 3-epiandrosterone (12)
by tosylation followed by an elimination reaction (Scheme 4).
From all tested bases comprising inorganic and organic bases
such as 2,4,6-collidine or 2,6-lutidine, the combination of LiBr
and Li2CO3 gave the best result regarding the yield and the
regioselectivity. Unfortunately, the direct conversion with
p-toluenesulfonic acid adsorbed on silica gel50 did not afford
androst-2-ene 15 in satisfying yield and selectivity. We were
also able to obtain single crystals that were suitable for X-ray
crystallography (Fig. 5) confirming the stated position of the
double bond. The molecular structure shows that due to the
sp2 hybridization the A-ring adapts a half chair conformation.
When comparing both structures, the steric strain for the
androst-3-ene is higher than for its regioisomer explaining the
observed regioselectivity of the elimination favoring the more
stable androst-2-ene 15.
As previously reported for comparable examples,51 the treat-
ment with catalytic amounts of OsO4 and NMO as stoichio-
metric oxidant favors in our case the formation of the unde-
Scheme 4 Synthesis of the 2β,3β-cis-diol 21 according to the second
generation route. (a) p-TsCl, pyridine, r.t., 16 h, 92%; (b) LiBr, Li2CO3,
DMF, 175 °C, 7 h, 95%; (c) α-AD-mix, MeSO2NH2, tBuOH/H2O, r.t., 12 h,
61% (23); (d) β-AD-mix, MeSO2NH2, tBuOH/H2O, r.t., 7 d, 41%; (e)
m-CPBA, CH2Cl2, r.t., 14 h, 75%; (f ) 2 m H2SO4, THF, r.t., 7 d, 54%; (h)
HOCH2CH2OH, p-TsOH, HC(OMe)3, CH2Cl2, r.t., 16 h, 88%; DOS =
diversity orientated synthesis.
Scheme 3 Synthesis of the precursor 14-Ac and 14-Bn according to
the first generation route. (a) Ac2O, pyridine, r.t., 16 h, 98%; (b) NaBH4,
MeOH, −20 °C → 0 °C, 3 h, 98%; (c) TBSCl, imidazole, DMF, r.t., 16 h,
80% or BnCOvNHCCl3, TfOH, 1,4-dioxane, r.t., 16 h, 82%; (d) KOH,
MeOH, Δ, 5 h; (e) NMO, cat. TPAP, CH2Cl2, 0 °C → r.t., 16 h or DMP,
CH2Cl2, 0 °C → r.t., 16 h, 90% (17-TBS)/79% (17-Bn) over two steps; (f )
HClO4, Ac2O, EtOAc, r.t., 3 h, 69% (16-Ac)/77% (16-Bn); (g) m-CPBA,
CH2Cl2, 0 °C → r.t., 16 h, 70% (18-Ac)/47% (18-Bn); (h) pyridine/toluene
(1 : 10), Δ, 16 h, 86% (19-Ac)/75% (19-Bn); (i) iPrOH, K2CO3, H2O, r.t.,
16 h, 58% (20-Ac)/48% (20-Bn); ( j) NaBH4, MeOH, −20 °C → 0 °C, 3 h,
76% (14-Ac)/82% (14-Bn); TBS = tert-butyldimethylsilyl; Bn = benzyl.
Research Article Organic Chemistry Frontiers
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sired 2α,3α-cis-diol 22, whereas the corresponding 2β,3β-cis-
diols are reported to be prepared by the addition of iodine fol-
lowed by a nucleophilic displacement with acetate in the pres-
ence of water and the hydrolysis of the intermediately formed
ester using AgOAc,52,53 Tl(OAc)3
54 or CuOAc.55 Driven by the
idea of a direct conversion of androst-2-ene to the corres-
ponding 2,3-cis-diol, we contemplated a Sharpless dihydroxyla-
tion adjusting the side of attack by the choice of the
ligand.56,57 While the AD-mix β introduces the hydroxyl groups
at the sterically more accessible α-side to build the 2α,3α-cis-
diol 22, the use of AD-mix α mainly forms the desired, but
sterically more demanding 2β,3β-cis-diol 21. Despite the
reported accelerating effect of methanesulfonamide,58 long
reaction times of 7 days were required with commercially avail-
able AD-mix α. While the extra addition of OsO4 or
K2[OsO2(OH)4] did not lead to a faster conversion of the start-
ing material, 2.5 equiv. of “self-made” reduces luckily the reac-
tion time to only 12 h even on 0.1 mmol scale (please see ESI†
for further information). However, the corresponding 2,3-cis-
diols were obtained in good yields and selectivities.
Different C-17 derivatives bearing a ketal (27) or TBS/Bn
protected OH-group (18-OH, 18-TBS, 18-Bn) at C-17 were syn-
thesized and subjected to the developed reaction conditions
generating the corresponding 2β,3β-cis-diols (29 and 30) in
good yields. Unfortunately, the purification via column chrom-
atography on silica turned challenging resulting in rather low
isolated yields (please see ESI†).
When androst-2-ene 15 was reacted with m-CPBA followed
by an acid-catalyzed epoxide ring-opening, the 2β,3α-trans-diol
was obtained. Once more, the reagents attack occurred from
the sterically less hindered α-side releasing the 2α,3α-epoxide
24 with 75% yield. The epoxide was opened by simple acidic
treatment to afford with its diaxial 2β,3α-substituents the least
stable 2,3-diol.
Even though 2α,3β-trans-diol 27 is not accessible from the
precursor 15, the missing trans-diol can be synthesized by a
five-step procedure from 3-epiandrosterone (12) (Scheme 5).
The synthesis starts with the protection of the keto functional-
ity at C-17 followed by the oxidation of the hydroxyl group at
C-3 enabling the stereo- and regioselective introduction of an
α-hydroxyl group at C-2 by a Rubottom oxidation. This was
accomplished by the conversion of 25 to the corresponding
TMS-enol ether, its epoxidation with m-CPBA and a consecu-
tive ring-opening followed by a silyl migration and finally the
cleavage of the silyl group to give 26. By reducing the reaction
time for the cleavage with oxalic acid or by replacing it by
TBAF, the 2α-hydroxylated androstan-3-one was formed
with improved yields of about 56%, 66% respectively.
Diastereoselective reduction from the sterically less hindered
side and removal of the acetal protecting group with p-PTSA
result in the formation of the 2α,3β-trans-diol 27 which
shows the same configuration at C-2 and C-3 as calotropagenin
(11).
We were able to obtain suitable single crystals from the four
diastereomeric 2,3-diols which are depicted in Fig. 5. The
stated molecular structures and orientation of the substituents
could be confirmed. The naturally occurring 2α,3β-diol rep-
resents with its diequatorial substituents the thermo-
dynamically preferred and therefore most stable diastereomer,
while the other trans-diol possesses two axial hydroxyl groups
causing an increased transannular strain. The 1,3-diaxial inter-
action explain also the preferred formation of the 2α,3α-cis-
diol 22 over the 2β,3β-cis-diol 21 since the latter owns an axial
hydroxyl group at C-2 which conflicts with the 19-methylgroup
while in case of the other diastereomer the hydroxyl group at
C-2 is equatorially orientated reducing the overall transannular
strain.
With 2β,3β-cis-diol 21 in hands, we demonstrated the need
of a hydroxyl group protected at C-3 in the directed sp3 C–H
oxidation reaction (Scheme 6). Therefore, we exposed the
2β,3β-cis-diol 21 to the later developed reaction conditions of
the C–H oxidation reaction. Although full conversion of the
2β,3β-cis-diol 21 was observed, no formation of the desired
product was detected. Instead, the dialdehyde 28 was isolated
in 48% yield generated by glycol cleavage affirming the rele-
vance of the protection group in order to avoid glycol cleavage.
In order to furnish a regioselective protection of the 3-OH
group,59–62 several lipases comprising different yeast lipases
(C. cylindracea, C. rugosa, C. antarctica), a mold lipase (Mucor
miehei), one porcine pankrease and a lipase extracted from the
Gram-negative bacterium pseudomonas fluorescens, were evalu-
ated. The esterification reactions were run in toluene or tert-
butanol as solvent, all at 36 °C using vinyl acetate as acetyl
donor whereby the esterification progress was monitored via
TLC. Three of the tested lipases showed partial or complete
conversion in toluene within 2 d: in the case of C. cylindracea
and pseudomonas fluorescens the formation of a unknown
byproduct was observed, whereby C. rugosa delivered only one
product which was determined as the desired 3-acetylated
2β,3β-diol 14. By lowering the reaction temperature to r.t. and
modifying the reaction experimental setup, an upscale on mul-
tigram scale was succeeded providing the 3-acetylated
2β,3β-diol 14 in yields higher than 77%. For comparison, we
Scheme 5 Synthesis of the 2α,3β-trans-diol 27 starting from 3-epian-
drosterone (12). (a) HOCH2CH2OH, p-TsOH, HC(OMe)3, CH2Cl2, r.t.,
16 h, 88%; (b) DMP, CH2Cl2, 0 °C → r.t., 16 h, 80% (25); (c) I. TMSOTf,
NEt3, CH2Cl2, 0 °C, 1 h; II. m-CPBA, NaHCO3, n-hexane, 0 °C, 2 h; III.
C2H2O4, MeOH, r.t., 5 min; 56% (26) or III. TBAF, THF, r.t., 10 min; 66%
(26); (d) NaBH4, MeOH, CH2Cl2, −20 → 0 °C, 4 h, 66% (33); (e) p-PTSA,
acetone, r.t., 3 h, 88% (27).
Organic Chemistry Frontiers Research Article
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conducted a kinetically controlled acetylation of 2β,3β-diol 21
with 1.05 equiv. of acetyl chloride in pyridine giving the
desired product 14 in only 39% yield.
In order to oxidize the methyl group at C-19, a remote intra-
molecular free radical C–H oxidation was envisioned exploiting
the rigidity of the steroid and the close proximity of the OH-
group at C-2 and the C-19 methyl group. The obtained crystal
structure of 3-acetylated 2β,3β-diol 14 confirms the stated
structure and allows the determination of the distance
between the oxygen of the hydroxyl group at C-2 and C-19 or
its proton in the solid state to 2.928 Å and 2.278 Å, respectively.
In accordance with the literature,63–66 this proximity allows the
transfer of a radical from the alkoxy group to the methyl group
at C-19 via a hypoiodite reaction (Fig. 3). By using lead tetra-
acetate and iodine in overstoichiometric amounts,
androstane67–69 and cholestane70–72 derivatives have been suc-
cessfully oxidized.
Driven by the idea to replace toxic Pb(OAc)4 with DIB and
encouraged by the fundamental work of Suárez,73,74 we
initiated our studies by probing various reaction parameters
such as the amounts of reagents, the concentration, the
solvent, reaction time and temperature for the envisioned
hypoiodite reaction using 3-acetylated 2β,3β-diol 14 as sub-
strate (Table 1). Preliminary studies revealed problems with
reproducibility when a tungsten lamp or LED lamp were
deployed. Therefore, we report exclusively on a visible-light
free alternative and the usage of a sonication bath to produce
the required iodine radicals. In this case, we experienced
results that are more consistent and reliable. We noticed the
formation of four products including the desired A-ring brid-
ging ether 13, the iodide 30, the overoxidized iodide 31 and
the overoxidation product 32 (Table 1). The iodides 30 and 31
can be converted to 13 or respectively 32 by a nucleophilic sub-
stitution induced by silver acetate in acetone. All products can
be differentiated via 1H NMR spectroscopy, whereby the
spectra of 30 and 13 show some similarities (Fig. 4). For the
iodide 30 the proton at C-2 is shifted downfield, while the
proton at C-3 and the more shielded protons of the diastereo-
topic methylene group at C-16 are shifted upfield compared to
the signals of ether 13.
In the beginning, 1.5 equiv. of (diacetoxyiodo)benzene
(DIB) and 1.3 equiv. of iodine were used for the hypoiodite
reaction and the reaction was conducted at r.t. for 120 min
under sonication (entry 1). After column chromatography on
silica gel, the desired product 13 was isolated with 34% yield
together with 20% reisolated starting material. Therefore, both
the amounts of reagents and the reaction time were increased
(entries 2 and 3) giving finally the product with synthetically
useful 53% yield, although still small amounts of starting
material 14 remained. In order to run the reaction at higher
concentrations, we added benzene as co-solvent to increase
the solubility of 14 and DIB. Keeping the amounts of reagents
constant, we screened the reaction times for a higher concen-
trated solution of 14 (entries 4–6). After 140 min the desired
ether 13 was isolated with an improved yield of 69% (entry 6)
and no starting material was remained. Instead, the formation
of hemiacetal acetate 32 was observed presumably as a result
of a second hypoiodite reaction due to an excess of reagents.
In order to figure out which parameters promote overoxida-
tion, we applied harsher reaction conditions. At higher temp-
eratures for example the ratio of the desired and double oxi-
dized product shifts towards overoxidation (entry 7). Since the
amount of applied reagents should have an effect on the ratio
of the two products, we kept reaction time at 140 min, but
reduced the amounts of reagent. In this case we observed a
dramatic drop in yield of the desired ether 13 (entry 8). In
summary, increased amounts of reagent or elevated reaction
times led to higher and faster conversion of the starting
material, but also to an enhanced formation of the hemiacetal
acetate 32 (not shown). Fine tuning of all these parameters
finally provides the ether 13 with 72% yield (entry 9). Since the
Scheme 6 Transformation of the 2β,3β-cis-diol 21 to 2α,3β-trans-19-
triacetate 29. (a) Candida rugosa, vinyl acetate, toluene, r.t., 2 d, >77%
(14) or (b) AcCl (1.05 equiv.), pyridine, 40 h, r.t., 39% (14); (c) DIB, I2,
cyclohexane, C6H6, 30–39 °C, 80 min, sonication (∼), 48% (28)/72% (13);
(d) Zn(OTf)2, Ac2O, 45 °C, 16 h → 60 °C, 2 h, 68% (29).
Fig. 3 Molecular structure of 14 and 13-Bn (displacement parameters
are drawn at 50% probability level) including distance measurements
from oxygen at C-2 to the hydrogen at C-19 of 14. Characteristic angles
(relative deviations from the standard angle of 111.4°) of 13-Bn: C1–C2–
C3: 109.50(16)° (−1.7%), C2–C3–C4: 110.53(14)° (−0.79%), C3–C4–C5:
113.39(15)° (+1.8%), C4–C5–C10: 111.74(15)° (+0.31%), C5–C10–C1:
106.72(14)° (−4.2%), C10–C1–C2: 100.00(14)° (−10%).
Research Article Organic Chemistry Frontiers
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hemiacetal acetate 32 already possess the correct oxidation
state at C-19, we were also interested how its formation can be
promoted. By the addition of higher equivalents of reagents
(entry 10) and prolonged reaction times (entry 11), the ratio of
the ether 13 and the hemiacetal acetate 32 could be increased
in the direction of the latter.
The molecular structure of the C-17 benzyl protected ether
derivative 13-Bn by X-ray crystallography confirms the for-
mation of the bridging ether (Fig. 3) and shows a deformation
of the chair geometry on the A-ring induced by the bridging
ether. In particular, the angles close to the bridging THF ring
differ by up to 10% from the usual angle of 111.4° with values
of 106.72(14)° (C5–C10–C1) or 100.00(14)° (C10–C1–C2).
The final step for the synthesis focused on the nucleophilic
substitution in order to open the previously constructed brid-
ging THF ring which leads concurrently to an integration of
the desired oxygen functionality at C-19. Since the ring-
opening requires an activation for instance by a Lewis acid, we
selected boron trifluoride diethyl etherate being widely used
for the opening of cyclic ethers75,76 or the transformation of
methyl ethers into acetyl ester.77–80 If applied to the C-17
acetyl protected ether 13-Ac or the C-17 benzyl protected ether
13-Bn, the same ring-opened product was obtained, both in
good yields of greater than 70% (see ESI†). Unfortunately, the
selective cleavage of just one ether moiety of the C-17 benzyl
protected ether derivative 13-Bn did not succeeded. However,
same reaction conditions applied to ether 13 (Table 2, entry 1)
did not cleave the cyclic ether. Even if the reaction temperature
and/or the amount of BF3·OEt2 were increased, mainly starting
material was recovered accompanied by small amounts of an
unknown byproduct. Hernandez et al.81 reported that a combi-
nation of ZnI2 and Ac2O can initiate the opening of cyclic
ethers. At elevated reaction temperatures of 40 °C, we did
observe the formation of the desired product for all three
cyclic ethers (compare entries 2 and 3), along with the iodide
34 – in most cases as a byproduct, but occasionally even as the
main product. To overcome this drawback further zinc(II) salts
were tested (entries 4–7). When Zn(OAc)2 was added (entry 4),
no conversion to the desired product 29 was determined. In
case of ZnBr2, a similar reaction outcome was observed as with
ZnI2 as Lewis acid (entry 5) yielding the undesired bromide 33
as byproduct. Luckily, a Zn(OTf)2 induced ring-opening reac-
tion gave the desired product 29 in 68% yield (entry 6). Since
small amounts of starting material remained, more reagent
was applied, but instead of improving the yield, the latter
decreased even though full conversion was achieved (entry 7).
Noteworthy, the hemiacetal acetate 32 forms under the same
reaction conditions the corresponding aldehyde 43 (not
shown).
Experimental section
General procedure for the dihydroxylation (GP-1)
The androst-2-ene derivative (1.0 equiv.) was dissolved in tert-
BuOH and the required commercially AD-mix, dissolved in the
same amount of H2O, was added. The mixture was stirred for
10 min at r.t. before MeSO2NH2 (0.40 equiv.) was added. The
yellow suspension was stirred vigorously for 7 d at r.t. and was
Table 1 Evaluation of the optimal reaction conditions for the radical
(sp3)C–H oxidation of C-19
Entry
DIB
[equiv]
I2
[equiv]
Reaction
conditionsa
Isolated yield [%]
of (x)
1 1.5 1.3 cyb, 20–30 °C 34 (13)
120 min 20 (14)
2 2.0 1.5 cyb, 20–30 °C 38 (13)
139 min 35 (14)
3 2.2 1.5 cyb, 20–30 °C 53 (13)
150 min 16 (14)
4 2.2 1.5 cy/C6H6
c, 20–30 °C 39 (13)
100 min 18 (30)
5 2.2 1.5 cy/C6H6
c, 20–30 °C 39 (13)
120 min <18 (30)
6 2.2 1.5 cy/C6H6
c, 20–30 °C 69 (13)
140 min 21 (32)
7 2.2 1.5 cy/C6H6
c, 30–50 °C 50 (13)
140 min 30 (32)
8 2.0 1.4 cy/C6H6
c, 20–25 °C <16 (30)
140 min 27 (13)
9 2.0 1.2 cy/C6H6
c, 20–30 °C 72 (13)
200 min 14 (32)
10 4.4 3.0 cy/C6H6
c, 20–30 °C 62 (13)
140 min 37 (32)
11 4.4 3.0 cy/C6H6
c, 20–30 °C 58 (13)
200 min 34 (32)
a AgOAc, acetone, r.t., overnight; cy = cyclohexane. b c = 10 mm. c c =
30 mm.
Fig. 4 1H NMR spectra (500 MHz, CDCl3, r.t.) of the iodide 30 (red) and
the desired ether 13 (blue).
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then quenched with saturated aqueous Na2S2O3 solution. After
extraction with EtOAc (3×) the combined organic phases were
washed consecutively with 2 m aqueous solution of KOH, H2O
and brine. The organic phases were dried over Na2SO4, filtered
and the solvent was removed. The residue was purified by
flash column chromatography on silica gel (cHex/EtOAc) to
obtain the corresponding cis-diol as a colorless powder.
Please note that the reaction times can be reduced when
2.5 equiv. of “self-made” AD-mix were used (please see ESI†).
General procedure for the C–H oxidation via a hypoiodite
reaction (GP-2)
A suspension of DIB (1.5 equiv.) and I2 (1.3 equiv.) in a
mixture of cyclohexane and benzene (10 : 1, 25–30 mm) was
degassed by bubbling with argon (15 min) which was followed
by the addition of the 2β-acetoxy-3β-hydroxyandrostane deriva-
tive (1.0 equiv.). The reaction was sonicated at the given temp-
erature and for the given time before it was quenched with
saturated aqueous Na2S2O3 solution. After phase separation
the aqueous phase was extracted with CH2Cl2 (3×) and the
combined organic extracts were washed with brine and dried
over Na2SO4. After filtration and evaporation the obtained
crude product was purified by flash column chromatography
on silica gel (cHex/EtOAc) to afford the 2β,19-epoxy-
5α-androstane derivative as colorless solid.
General procedure for the Lewis acid-mediated opening of the
THF ring (GP-3)
A. The 2β,19-epoxy-5α-androstane derivative, the Zn(II) salt
(1.5 equiv.–3.5 equiv.) and Ac2O were heated at 40 °C for 16 h.
For completion, the mixture was stirred at 60 °C for further 2 h
and then cooled to r.t.
B. The 2β,19-epoxy-5α-androstane derivative was dissolved in
Ac2O and cooled to −30 °C. Then BF3·OEt2 (3.8 equiv.–10.0
equiv.) was added dropwise and the resulting mixture was
stirred for a few hours and warmed to −10 °C. Afterwards the
Table 2 Lewis acid-mediated THF opening to form the 2α,3β,19-trans-triacetate 29
Entry Lewis acid Reaction conditions Isolated yield [%]
1 20 equiv. BF3·OEt2 Ac2O, −30 °C→ 0 °C, 4 h 0a
2 1.4 equiv. ZnI2 Ac2O, r.t., 16 h 0
a
3 1.5 equiv. ZnI2 Ac2O, 40 °C, 16 h 20
b
4 1.5 equiv. Zn(OAc)2 Ac2O, 40 °C, 16 h→ 60 °C, 2 h 0
a
5 1.5 equiv. ZnBr2 Ac2O, 40 °C, 16 h→ 60 °C, 2 h 0
c
6 1.5 equiv. Zn(OTf)2 Ac2O, 45 °C, 16 h→ 60 °C, 2 h 68
7 2.0 equiv. Zn(OTf)2 Ac2O, 45 °C, 16 h→ 60 °C, 2 h 56
aMainly starting material was detected accompanied by an unidentified byproduct. b The formation of 34 was observed. c The formation of 33
was observed.
Fig. 5 Overview of the synthetic strategies for the four possible 2,3-diol diastereomers starting from androst-2-ene 15 (middle) and their molecular
structures (displacement parameters are drawn at 50% probability level). The cis-2,3-diol alcohols 22 and 21 (right) were obtained by a Sharpless
dihydroxylation, whereas the trans-diol 23 (left) was accessible via an epoxidation followed by ring-opening. 27 (left) was synthesized from 3-epian-
drosterone (12) via a 5-step procedure.
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mixture was allowed to warm to r.t. and stirred for another
30 min.
For the work up, the reaction was added to a solution of
saturated aqueous NaHCO3 and stirred until the gas formation
stopped. After phase separation, the aqueous phase was
extracted with EtOAc (3×). The combined organic phases were
washed with H2O and brine, then dried over Na2SO4 and fil-
tered. Solvent removal gave the crude product which was puri-
fied by flash column chromatography on silica gel (cHex/
EtOAc).
Crystal structure determinations
The single-crystal X-ray diffraction study was carried out on a
Bruker D8 Venture diffractometer with Photon 100 detector
PhotonII CPAD (for 27) at 123(2) K using Cu-Kα radiation
(λ = 1.54178 Å. Direct Methods (SHELXS-97)82 or dual space
methods (SHELXT for 13-Bn and 27)83 were used for structure
solution and refinement was carried out using SHELXL-2014
(full-matrix least-squares on F2).83 Hydrogen atoms were loca-
lized by difference electron density determination and refined
using a riding model (H(O) free, except 21). Semi-empirical
absorption corrections were applied. For 15, 14-Ac, 27 and
20-Ac an extinction correction were applied. The absolute con-
figuration was determined by refinement of Parsons’ x-para-
meter84 or the enantiomer has been assigned by reference to
an unchanging chiral center in the synthetic procedure (see
cif-files for details). In 21 there seems to be a possible disorder
of the OH-groups at C3 and C4 (see cif-files for details).
15. Colorless crystals, C19H28O, Mr = 272.41, crystal size 0.14
× 0.20 × 0.08 mm, orthorhombic, space group P212121 (No. 19),
a = 6.4188(2) Å, b = 8.9046(3) Å, c = 26.9419(9) Å, V = 1538.91(9)
Å3, Z = 4, ρ = 1.175 Mg m−3, µ(Cu-Kα) = 0.527 mm
−1, F(000) =
600, 2θmax = 144.2°, 13 656 reflections, of which 3011 were
independent (Rint = 0.021), 182 parameters, R1 = 0.031 (for
2981 I > 2σ(I)), wR2 = 0.079 (all data), S = 1.08, largest diff.
peak/hole = 0.287/−0.172 e Å−3. x = −0.05(5).
21. Colorless crystals, C19H30O3, Mr = 306.43, crystal size
0.08 × 0.06 × 0.02 mm, monoclinic, space group P21 (No. 4), a =
6.0976(2) Å, b = 22.7525(7) Å, c = 6.2997(2) Å, β = 108.857(3)°, V =
827.08(5) Å3, Z = 2, ρ = 1.230 Mg m−3, µ(Cu-Kα) = 0.637 mm
−1,
F(000) = 314, 2θmax = 143.8°, 8766 reflections, of which 3222
were independent (Rint = 0.042), 199 parameters, 1 restraint, R1 =
0.063 (for 2741 I > 2σ(I)), wR2 = 0.169 (all data), S = 1.04, largest
diff. peak/hole = 1.003/−0.282 e Å−3. x = −0.2(2).
22. Colorless crystals, C19H30O3, Mr = 306.43, crystal size
0.16 × 0.10 × 0.02 mm, triclinic, space group P1 (No. 1), a =
7.0823(2) Å, b = 10.2458(3) Å, c = 12.0686(3) Å, α = 73.204(2)°,
β = 89–279(2)°, γ = 84.178(2)°, V = 833.93 Å3, Z = 2, ρ = 1.220
Mg m−3, µ(Cu-Kα) = 0.633 mm
−1, F(000) = 314, 2θmax = 144.6°,
15 480 reflections, of which 6149 were independent (Rint =
0.032), 399 parameters, 7 restraints, R1 = 0.042 (for 5585 I >
2σ(I)), wR2 = 0.104 (all data), S = 1.03, largest diff. peak/hole =
0.239/−0.179 e Å−3. x = 0.08(17).
23. Colorless crystals, C19H30O3, Mr = 306.43, crystal size
0.26 × 0.24 × 0.02 mm, monoclinic, space group P21 (No. 4), a =
9.5164(4) Å, b = 7.7586(3) Å, c = 11.9999(5) Å, β = 111.938(3)°,
V = 822.11(6) Å3, Z = 2, ρ = 1.237 Mg m−3, µ(Cu-Kα) =
0.642 mm−1, F(000) = 314, 2θmax = 144.4°, 9462 reflections, of
which 3203 were independent (Rint = 0.044), 205 parameters,
3 restraints, R1 = 0.052 (for 2917 I > 2σ(I)), wR2 = 0.114(all data),
S = 1.05, largest diff. peak/hole = 0.270/−0.290 e Å−3. x = 0.0(2).
33. Colorless crystals, C21H34O4, Mr = 350.48, crystal size
0.22 × 0.16 × 0.04 mm, monoclinic, space group P21 (No. 4),
a = 11.0162(3) Å, b = 6.7430(2) Å, c = 12.6811(3) Å, β =
103.877(2)°, V = 914.49(4) Å3, Z = 2, ρ = 1.273 Mg m−3,
µ(Cu-Kα) = 0.684 mm
−1, F(000) = 374, 2θmax = 143.6°, 14 546
reflections, of which 3541 were independent (Rint = 0.044), 232
parameters, 3 restraints, R1 = 0.045 (for 3243 I > 2σ(I)), wR2 =
0.109 (all data), S = 1.04, largest diff. peak/hole = 0.317/−0.191
e Å−3. x = 0.14(18).
27 colourless crystals, C19H30O3·H2O, Mr = 324.44, crystal
size 0.28 × 0.14 × 0.06 mm, orthorhombic, space group
P212121 (No. 19), a = 6.3125(4) Å, b = 13.3434(8) Å, c =
10.8575(12) Å, V = 1756.83(18) Å3, Z = 4, ρ = 1.227 Mg m−3,
µ(Cu-Kα) = 0.671 mm−1, F(000) = 712, 2θmax = 144.4°, 17 174
reflections, of which 3469 were independent (Rint = 0.025), 220
parameters, 5 restraints, R1 = 0.032 (for 3439 I > 2σ(I)), wR2 =
0.087 (all data), S = 1.05, largest diff. peak/hole = 0.302/−0.267
e Å−3. x = −0.09(4).
14. Colorless crystals, C21H32O4, Mr = 348.46, crystal size
0.22 × 0.20 × 0.06 mm, monoclinic, space group P21 (No. 4),
a = 9.8746(3) Å, b = 7.6958(2) Å, c = 12.2229(4) Å, β = 92.870(1)°,
V = 928.14(5) Å3, Z = 2, ρ = 1.247 Mg m−3, µ(Cu-Kα) =
0.673 mm−1, F(000) = 370, 2θmax = 144.6°, 12 308 reflections, of
which 1455 were independent (Rint = 0.030), 230 parameters,
2 restraints, R1 = 0.029 (for 3588 I > 2σ(I)), wR2 = 0.076 (all
data), S = 1.04, largest diff. peak/hole = 0.187/−0.160 e Å−3.
x = 0.01(6).
13-Bn. Colorless crystals, C28H37O4, Mr = 437.58, crystal size
0.20 × 0.16 × 0.08 mm, monoclinic, space group P21 (No. 4), a =
9.6663(3) Å, b = 7.5343(2) Å, c = 16.3096(5) Å, β = 96.857(2)°, V =
1179.31(6) Å3, Z = 2, ρ = 1.235 Mg m−3, µ(Cu-Kα) = 0.636 mm
−1,
F(000) = 476, 2θmax = 144.4°, 17 473 reflections, of which 4591
were independent (Rint = 0.024), 290 parameters, 1 restraint,
R1 = 0.031 (for 4482 I > 2σ(I)), wR2 = 0.086 (all data), S = 1.05,
largest diff. peak/hole = 0.260/−0.161 e Å−3. x = 0.13(6).
14-Ac. Colorless crystals, C23H14O5, Mr = 382.52, crystal size
0.50 × 0.35 × 0.25 mm, orthorhombic, space group P212121
(No. 19), a = 7.7219(3) Å, b = 13.4724(4) Å, c = 20.1539(7) Å, V =
2096.67(13) Å3, Z = 4, ρ = 1.243 Mg m−3, µ(Cu-Kα) =
0.689 mm−1, F(000) = 856, 2θmax = 144.2°, 20 103 reflections, of
which 4139 were independent (Rint = 0.025), 260 parameters,
R1 = 0.028 (for 4106 I > 2σ(I)), wR2 = 0.075 (all data), S = 1.07,
largest diff. peak/hole = 0.214/−0.167 e Å−3. x = −0.02(4).
20-Ac. Colorless crystals, C23H34O5, Mr = 380.50, crystal size
0.15 × 0.03 × 0.01 mm, monoclinic, space group P21 (No. 4), a =
7.1015(3) Å, b = 25.1141(8) Å, c = 11.8745(4) Å, β = 92.269(2)°,
V = 2117.98(13) Å3, Z = 4, ρ = 1.225 Mg m−3, µ(Cu-Kα) =
0.682 mm−1, F(000) = 848, 2θmax = 114.4°, 12 893 reflections, of
which 7180 were independent (Rint = 0.047), 40 parameters,
1 restraint, R1 = 0.064 (for 5010 I > 2σ(I)), wR2 = 0.147 (all data),
S = 1.02, largest diff. peak/hole = 0.178/−0.173 e Å−3. x = 0.4(3).
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CCDC 1998175 (27), CCDC 1822521 (15), CCDC 1822522
(21), CCDC 1822523 (22), CCDC 1822524 (23), CCDC 1822525
(33), CCDC 1822526 (14), CCDC 1822527 (13-Bn), CCDC
1822528 (14-Ac), and 1822529 (20-Ac) contain the supplemen-
tary crystallographic data for this paper.†
Conclusions
Due to the interesting biological properties of calotropin (4)
and related cardenolides, we herein presented a modular
synthetic route for these cardenolide aglyocones. The pre-
sented work enables the regioselective C–H oxidation of the
methyl group at C-19 followed by the subsequent introduc-
tion of the 2α,3β-trans-diol moiety in order to enable the
connection to the sugar moiety. We faced two synthetic
routes for the preparation of the precursor 14 for the remote
C–H oxidation starting from commercially available 3-epian-
drosterone (12). The first generation route based on tra-
ditional steroid chemistry could be replaced by a more con-
venient and efficient sequence of an asymmetric Sharpless
dihydroxylation and a regioselective acetylation. With
androst-2-ene as intermediate not only the synthesis of the
required 2β,3β-cis-diol was accomplished, but also two more
diastereomeric 2,3-diols became accessible. The corres-
ponding 2α,3β-trans-diol is not accessible from androst-2-ene,
but can be accessed from 3-epiandrosterone via a Rubottom
oxidation and a consecutive reduction of the 3-keto group.
Due to the close proximity of the axial C-2 hydroxyl and
C-19 methyl group in the steroidal framework, a remote
intramolecular radical C–H oxidation of C-19 with DIB and
I2 (hypoiodite reaction) led to the formation of the A-ring
bridging ether which was then opened by a Lewis acid-
mediated ether cleavage to give the 2,3,19-triacetoxy deriva-
tive 29. The overoxidation product 32, resulting from a
double hypoiodite reaction under harsher reaction con-
ditions, can be directly converted to the desired aldehyde
functionality at C-19 after acidic treatment.
In summary, we have devised a novel strategy towards all
2,3-diol diastereomers and the introduction of an oxygen func-
tionality at C-19 via a remote C–H oxidation without using any
light source or transition metal. The herein presented method
should not only allow the synthesis of calotropin (4) and
related cardenolides, but should also inspire upcoming syn-
thesis of steroids and cyclic terpenes.
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